Advertisement
Advertisement
Trending on Urology Times
1
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
2
Radioligands and ADT alternatives emerge in prostate cancer treatment
3
Stacy Loeb, MD, highlights long-term data on PSA screening
4
Beyond PSA: Jonathan Henderson, MD, on precision tools for prostate cancer
5
